|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2004-10-29
|
|
pubmed:abstractText |
The rates of early death (ED) and treatment-related mortality (TRM) are unacceptably high in children undergoing intensive chemotherapy for acute myeloid leukemia (AML). Better strategies of supportive care might help to improve overall survival in these children.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4384-93
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15514380-Adolescent,
pubmed-meshheading:15514380-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15514380-Cause of Death,
pubmed-meshheading:15514380-Chi-Square Distribution,
pubmed-meshheading:15514380-Child,
pubmed-meshheading:15514380-Child, Preschool,
pubmed-meshheading:15514380-Cytarabine,
pubmed-meshheading:15514380-Dose-Response Relationship, Drug,
pubmed-meshheading:15514380-Drug Administration Schedule,
pubmed-meshheading:15514380-Etoposide,
pubmed-meshheading:15514380-Female,
pubmed-meshheading:15514380-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:15514380-Humans,
pubmed-meshheading:15514380-Idarubicin,
pubmed-meshheading:15514380-Incidence,
pubmed-meshheading:15514380-Infant,
pubmed-meshheading:15514380-Infant, Newborn,
pubmed-meshheading:15514380-Leukemia, Myeloid, Acute,
pubmed-meshheading:15514380-Logistic Models,
pubmed-meshheading:15514380-Male,
pubmed-meshheading:15514380-Mitoxantrone,
pubmed-meshheading:15514380-Randomized Controlled Trials as Topic,
pubmed-meshheading:15514380-Retrospective Studies,
pubmed-meshheading:15514380-Risk Factors,
pubmed-meshheading:15514380-Survival Rate
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
|
|
pubmed:affiliation |
Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Str 33, D-48129 Muenster, Germany. ursula@creutzig.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
